Holen Sie sich die Stockscreener-App
2.07
6.15%
0.12
Handel nachbörslich:
2.08
0.01
+0.48%
Schlusskurs vom Vortag:
$1.95
Offen:
$1.96
24-Stunden-Volumen:
349.67K
Relative Volume:
0.58
Marktkapitalisierung:
$208.17M
Einnahmen:
$447.48M
Nettoeinkommen (Verlust:
$-14.55M
KGV:
-13.80
EPS:
-0.15
Netto-Cashflow:
$7.61M
1W Leistung:
+13.11%
1M Leistung:
-1.43%
6M Leistung:
+19.65%
1J Leistung:
-23.33%
1-Tages-Spanne:
$1.939
$2.08
1-Wochen-Bereich:
$1.76
$2.10
52-Wochen-Spanne:
$1.40
$2.99
Accuray Inc Stock (ARAY) Company Profile
Firmenname
Accuray Inc
Sektor
Branche
Telefon
608-824-2800
Adresse
1240 DEMING WAY, MADISON, CA
Vergleichen Sie ARAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARAY
Accuray Inc
|
2.07 | 208.17M | 447.48M | -14.55M | 7.61M | -0.15 |
|
ABT
Abbott Laboratories
|
113.83 | 197.43B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
361.52 | 137.82B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
90.69 | 133.66B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
80.95 | 103.80B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
73.91 | 43.59B | 6.60B | 4.16B | 490.10M | 6.93 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-13 | Eingeleitet | ROTH MKM | Buy |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-12-22 | Eingeleitet | Loop Capital | Buy |
| 2020-01-21 | Hochstufung | BTIG Research | Neutral → Buy |
| 2018-11-01 | Hochstufung | Citigroup | Sell → Neutral |
| 2017-12-13 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-11-30 | Eingeleitet | Lake Street | Buy |
| 2016-12-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2015-12-22 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2015-11-12 | Eingeleitet | Citigroup | Sell |
| 2015-05-01 | Bestätigt | Dougherty & Company | Buy |
| 2015-01-12 | Eingeleitet | Northland Capital | Outperform |
| 2014-01-31 | Bestätigt | Dougherty & Company | Buy |
| 2014-01-29 | Bestätigt | Brean Capital | Buy |
| 2013-11-11 | Bestätigt | Dougherty & Company | Buy |
| 2013-08-29 | Bestätigt | Dougherty & Company | Buy |
| 2011-09-20 | Bestätigt | Ticonderoga | Buy |
| 2010-02-08 | Hochstufung | Jefferies & Co | Hold → Buy |
| 2009-12-09 | Hochstufung | UBS | Sell → Neutral |
| 2009-03-09 | Herabstufung | Soleil | Buy → Hold |
| 2009-01-30 | Hochstufung | Piper Jaffray | Neutral → Buy |
| 2008-12-22 | Bestätigt | Jefferies & Co | Hold |
| 2008-08-20 | Bestätigt | Jefferies & Co | Hold |
Alle ansehen
Accuray Inc Aktie (ARAY) Neueste Nachrichten
Barclays PLC Acquires 104,310 Shares of Accuray Incorporated (NASDAQ:ARAY) - Defense World
Accuray (ARAY) Stock Surges Over 5% Amid Market Activity - GuruFocus.com
Here Is Why Bargain Hunters Would Love Fast-paced Mover Accuray (ARAY) - Yahoo Finance
Here's Why You Should Add Accuray Stock in Your Portfolio Now - MSN
Accuray Incorporated (NASDAQ:ARAY) Holdings Raised by State Street Corp - Defense World
Accuray (NASDAQ:ARAY) Stock Price Crosses Above 200-Day Moving Average – Time to Sell? - Defense World
Study: CyberKnife System Provides Safe, Effective Treatment Option to Control Brainstem Metastases - Imaging Technology News
Accuray Loses US$24m Market Value But Insiders See Windfall Of US$23k - Yahoo Finance
Accuray reports new data from multicenter analysis of SRS and FSRT - Yahoo Finance
New Data Indicates the CyberKnife® System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to Treat - PR Newswire
Accuray's CyberKnife Shows 83% Success Rate in Groundbreaking Brain Cancer Study - StockTitan
BNP Paribas Financial Markets Grows Holdings in Accuray Incorporated (NASDAQ:ARAY) - Defense World
Looking for a Fast-paced Momentum Stock at a Bargain? Consider Accuray (ARAY) - Yahoo Finance
Radiotherapy Market Detailed In New Research Report 2024 | - openPR
Linear Accelerators For Radiation Market Overall Study Report - openPR
Accuray Incorporated Announces the Departure of Michael Hoge as Senior Vice President, Global Operations, Effective January 6, 2025 - Marketscreener.com
Here's Why You Should Add Accuray Stock In Your Portfolio Now - Barchart
Accuray Incorporated: Cheap, But With Caveats (NASDAQ:ARAY) - Seeking Alpha
Accuray (FRA:XEJ) Growth Rank : 5 (As of Dec. 04, 2024) - GuruFocus.com
Connor Clark & Lunn Investment Management Ltd. Increases Stock Position in Accuray Incorporated (NASDAQ:ARAY) - MarketBeat
Medical Robots Market to Witness Massive Growth at USD 34.32 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.
Accuray Incorporated announces inducement award - Medical Buyer
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules - PR Newswire
Asia-Pacific Radiation Oncology Market Analysis Report 2025-2030External Beam Radiation Therapy (EBRT) Dominated the Market with a Revenue Share of 35.9% in 2024 - Yahoo Finance
Accuray Stockholders Approve Plans and Appoint New Officer - TipRanks
Accuray Incorporated Approves to Appoint Michael Murphy as the Principal Accounting Officer, Effective December 2, 2024 - Marketscreener.com
Heidelberg University Hospital in Germany Invests in Fourth Accu - GuruFocus.com
FY2026 Earnings Forecast for Accuray Issued By Roth Capital - MarketBeat
Accuray Incorporated (NASDAQ:ARAY) Shares Bought by Foundry Partners LLC - MarketBeat
Equities Analysts Offer Predictions for Accuray Q2 Earnings - Defense World
Roth Capital Brokers Reduce Earnings Estimates for Accuray - MarketBeat
Accuray (ARAY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Accuray (ARAY) Reports Q1 Loss, Tops Revenue Estimates - MSN
Medical Linear Accelerator Market to Boost Revenue Potential, - openPR
Royce & Associates LP Has $3.39 Million Stake in Accuray Incorporated (NASDAQ:ARAY) - MarketBeat
Non Melanoma Skin Cancer Market Expected To Reach $24.3 Billion - openPR
Accuray (NASDAQ:ARAY) Rating Lowered to "Hold" at StockNews.com - MarketBeat
Bridging Gaps and Making Precision Oncology Accessible Across India with Accuray - Elets
Accuray (NASDAQ:ARAY) Stock Rating Upgraded by StockNews.com - Defense World
Oncology Information Systems Market May See a Big Move| Accuray, Varian Medical Systems, DOSIsoft, ViewRay - openPR
Accuray Incorporated (NASDAQ:ARAY) Q1 2025 Earnings Call Transcript - Insider Monkey
Radiation Therapy Equipment Market Dynamics and Strategies - openPR
Accuray Q1 Earnings Meet Estimates, Sales Beat, Gross Margin Shrinks - Yahoo Finance
Accuray Inc (ARAY) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth Initiatives - GuruFocus.com
Accuray Inc (ARAY) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance
Accuray Inc (ARAY) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... By GuruFocus - Investing.com Canada
Accuray Incorporated Reports Strong Start to Fiscal 2025 - TipRanks
Accuray: Fiscal Q1 Earnings Snapshot - San Francisco Chronicle
Accuray Inc (ARAY) Q1 FY2025 Earnings: Revenue Surpasses Estimat - GuruFocus.com
Accuray Inc. Optimistic Despite Revenue Decline - TipRanks
Accuray earnings beat by $0.01, revenue topped estimates - Investing.com UK
Finanzdaten der Accuray Inc-Aktie (ARAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Accuray Inc-Aktie (ARAY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Pervaiz Ali | SVP Chief Financial Officer |
Jun 04 '24 |
Sale |
1.70 |
2,701 |
4,597 |
402,542 |
| WHITTERS JOSEPH E | Director |
May 29 '24 |
Buy |
1.58 |
50,000 |
79,000 |
561,053 |
| WHITTERS JOSEPH E | Director |
May 28 '24 |
Buy |
1.54 |
50,000 |
77,045 |
511,053 |
| Hoge Michael | Senior VP Global Operations |
Mar 01 '24 |
Sale |
2.59 |
11,991 |
31,057 |
390,208 |
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):